Company Filing History:
Years Active: 2005-2006
Title: Bruce Sullenger: Innovator in Nucleic Acid Research
Introduction
Bruce Sullenger is a prominent inventor based in Westminster, CO (US). He has made significant contributions to the field of nucleic acid research, holding a total of 2 patents. His work focuses on innovative methods for manipulating nucleic acid molecules, which have important implications in biotechnology and medicine.
Latest Patents
Sullenger's latest patents include a method for splicing a target nucleic acid molecule with a separate nucleic acid molecule. This splicing process generally results in the production of a chimeric protein that exhibits advantageous features compared to the protein naturally produced from the target nucleic acid prior to splicing. The method involves contacting the target nucleic acid molecule with a catalytic nucleic acid molecule that includes the separate nucleic acid molecule. This contacting is performed under specific conditions that allow at least a portion of the separate nucleic acid molecule to be spliced with at least a portion of the target nucleic acid molecule, resulting in the formation of a chimeric nucleic acid molecule. Importantly, the catalytic nucleic acid molecule is selected so that it is not naturally associated with the separate nucleic acid molecule.
Career Highlights
Bruce Sullenger is affiliated with the University of Colorado, where he continues to advance research in his field. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Sullenger has collaborated with notable scientists, including Thomas R. Cech, further enhancing the impact of his research.
Conclusion
Bruce Sullenger's work in nucleic acid research exemplifies the spirit of innovation and the potential for scientific advancements to improve our understanding of molecular biology. His contributions continue to influence the field and inspire future research endeavors.